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INTRODUCTION
Osteoarthritis (OA) is the most common joint 
disorder in the world. Radiographic evidence of 
OA is seen in the majority of people by 65 years 
of age, and in about 80% of those aged over 75 
years (1). OA of the knee, the principal joint to be 
affected, is a common clinical problem: 2% of the 
United States population over seventeen years of 
age and 10% of people over sixty-five years of 
age have clinically relevant arthritis of the knee 
(2). Arthritis of the knee causes pain and restricts 
activity, and patients with arthritis are twice as 
likely to seek medical care as are their peers 
without arthritis (3). The risk of disability due to 
knee OA alone is as great as that due to cardiac 
disease and greater than that due to any other 
medical disease in the elderly (4).
The most common symptom of arthritis of the 
knee is pain confined to the affected 
compartment(s), which may be associated with 
swelling, effusion, instability, impingement, 
crepitus, stiffness, and malalignment. 
Radiographic findings of knee arthritis may 
include joint space narrowing, squaring of the 
femoral condyle, subchondral sclerosis, 
intercondylar spurring, joint line osteophytes, and 
varus or valgus malalignment of the affected limb
(5).
The etiology of OA is multifactorial and various 
risk factors are known to increase the 
susceptibility to OA. These include heredity,
obesity, reproductive variables, age, 
hypermobility, and mechanical factors like joint 
trauma, abnormalities of joint shape, and various 
occupations and activities (1). Although age is 
the strongest risk factor for OA, it is not possible 
to see OA as a form of premature aging. Various 
differences can be set between osteoarthritis and 
aging.
The medial compartment of the knee is overall 
more affected than the lateral compartment of the 
knee. “Unicompartmental” arthritis of the knee is 
a degenerative condition characterized by 
abnormal articular cartilage in the medial part of 
the tibiofemoral joint, which may be associated 
with meniscal disruption, ligamentous instability, 
and limb malalignment. The most common 
symptom is pain confined to the medial 
compartment, which may be associated with 
other symptoms of OA (6).
Natural History
The specific cause of degenerative arthritis of the 
knee is not clear, but when it occurs in an active 
patient, it is generally progressive (7, 8). Trauma 
is frequently a cause of the degenerative 
process, which results in the deterioration of 
articular cartilage and symptomatic degenerative 
arthritis (6). The degenerative process may 
include articular cartilage damage (chondrocytes 
and matrix), meniscal damage, ligament 
damage, and joint incongruity.
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Angular malalignment may contribute to the 
development and progression of 
unicompartmental arthritis of the knee by 
overloading the medial aspect of a tibiofemoral 
joint with abnormal articular cartilage. The 
spectrum of articular cartilage damage can range 
from minimal to severe. Small, superficial, focal 
defects of articular cartilage that are not 
associated with the symptoms should be 
distinguished from extensive, full-thickness 
cartilage defects associated with symptomatic 
degenerative arthritis (9).
The location and size of articular cartilage 
defects determine the severity of symptoms and 
the need for treatment (9). When an articular 
cartilage lesion is less than 2 to 3 cm2 in area, or 
a lesion has good peripheral cartilage support 
(shoulders), it may take several years before 
degenerative arthritis develops. Minas and 
Nehrer (9) suggested that articular cartilage 
defects in which the exposed subchondral bone 
is not supported by a peripheral cartilage border 
are often symptomatic and deteriorate more 
quickly. Symptomatic lesions of articular cartilage 
often progress with age, and treatment of 
isolated chondral or osteochondral defects may 
decrease or minimize the development of 
degenerative arthritis.
Diagnosis and Evaluation
In the diagnosis of osteoarthritis the most widely 
used criteria were developed by the American 
College of Rheumatology (10) (Table I). History 
and physical examination can provide useful 
clues about pain, stiffness, joint line tenderness, 
meniscal damage, ligamentous instability, and 
malalignment associated with unicompartmental 
arthritis of the knee.
Radiographic evaluation is an essential 
component in the diagnosis and follow-up of 
knee OA. Several radiographic grading systems 
are proposed. Most epidemiologic systems 
propose the simple Kellgren-Lawrence system, 
which was first described in 1957. This system 
assigns one of five grades (0 to 4) at various joint 
sites (knee, hip, hand and spine) according to 
sequential appearance of osteophytes, joint 
space loss, sclerosis, and cysts (1) (Table II). 
Ahlback’s grading system is the most widely 
used one currently (1) (Table III).
Table I: The American College of Rheumatology diagnostic 
criteria for knee OA
Clinical
1. Knee pain for most days of the prior month 1.2,3,4
2. Crepitus on active joint motion or
3. Morning stiffness < 30 min in duration 1,2,5
4. Age > 38 years or
5. Bony enlargement of the knee on examination 1,4,5
Clinical and radiographic
1. Knee pain for most days of the prior month 1,2
2. Osteophytes at joint margins (radiograph)
or
3. Synovial fluid typical of OA (laboratory)
1,3,5
4. Age >  40 years
5. Morning stiffness <  30 min or
6. Crepitus on active joint motion 1,4,5,6
T a b le  II: Kellgren-Lawrence radiographic grading system for 
OA (1 ).
Grade Classification Description
0 Normal No features of 0A
1 Doubtful Minute osteophyte, doubtful significance
2 Minimal Definite osteophyte, unimpaired joint space
3 Moderate Moderate diminution of joint space
4 Severe Joint space greatly impaired with 
sclerosis of subchondral bone
T a b le  III: Ahlback grading system for OA.
Grade Description
Stage I Joint space narrowing
Stage II Joint space obliteration
Stage III Minor bone attrition
Stage IV Moderate bone attrition
Stage V Severe bone attrition
Stage VI Subluxation
Radiographs made in the anteroposterior plane 
with the patient bearing weight as well as lateral, 
tangential patellofemoral, and tunnel views allow 
objective evaluation of the three compartments of 
the knee (Fig. 1) Radiographic sensitivity with 
regard to showing deterioration of the articular 
cartilage may be improved by making 
posteroanterior views with the patient bearing 
weight and with the knee flexed 40° to evaluate 
the posterior aspects of the femoral condyles and 
tibial plateau, especially in the lateral 
compartment. Radiographs of the hip, knee, and 
ankle made on one long film with the patient
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T a b le  IV : Treatment alternatives for unicompartmental 
osteoarthritis
1. Conservative management
a. Non-Pharmacological treatment
i. Patient Education
ii. Weight Loss
iii. Exercise and Physical Therapy
iv. Support Devices and Braces
v. Footwear Modification and Orthotics
b. Pharmacological Treatment
i. Topical Agents
ii. Intraarticular Therapy
1. Corticosteroid injections
2. Intra-articular hyaluronate
iii. Oral Medications
1. Analgesic medications
2. Non-steroidal anti-inflammatory drugs
3. Opioid analgesics
iv. Adjunct Therapies
1. Nutritional Supplements
2. Other agents
2. Operative Management
a. Arthroscopy
b. Osteotomy
c. Unicompartmental Knee Arthroplasty
d. Total Knee Arthroplasty
F ig .1  s Plain AP view of a medial 
unicompartmental osteoarthritis 
patient
standing allow calculation of the static 
mechanical axis and identification of any angular 
deformity of the involved limb. (Fig. 2) The 
mechanical axis is determined by a line drawn 
from the center of the femoral head to the center 
of the knee joint and a line drawn from the center
F ig .2  : Various axis of the knee joint
of the knee joint through the center of the ankle 
joint. A mechanical axis of 0° to 3° of varus is 
considered to be within normal limits. Generally, 
a varus or valgus deviation of =10° is associated 
with symptoms of unicompartmental arthritis (6). 
Dynamic gait analysis can provide additional 
information about ligamentous insufficiency and 
malalignment. Before a specific treatment is 
selected, inflammatory arthritides should be 
excluded as a cause of unicompartmental 
arthritis.
In clinical practice, quantitative assessment is 
very important for both establishing the current 
status, detecting the change in status and also 
for quantification of response to therapy. In the 
“performance-based” assessment for patients 
with knee OA, we can use 50 foot walk time. In 
addition, WOMAC (Western Ontario and 
McMaster Universities Osteoarthritis Index) and 
Lequesne Index can be applied in the follow up of 
these patients (11).
Conservative Management of Knee 
Osteoarthritis
The objectives of management are; educating 
the patients, alleviating pain, improving function, 
decreasing disability and preventing the 
progression of the disease and its 
consequences. Current treatments aim at
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decreasing the symptoms by several methods: 
Non-pharmacological treatments,
pharmacological treatments and invasive 
interventions. (Table III) Various guidelines on 
the management of knee OA have been 
published. (3,4,9,12) Recent clinical research 
suggests a variety of agents that may alter the 
course of OA. Possible “disease modifying 
agents” are glucosamine, enzyme inhibitors 
(tetracyclines, metalloproteinase inhibitors), 
bisphosphonates, diacerein, cytokine inhibitors, 
and cartilage repair.
Non-Pharmatologieal Treatment
Patient Education
Patients should be given an education on their 
knee OA. The severity of their condition, various 
treatment options, necessary lifestyle changes, 
progression of the disease should be discussed 
with a language understandable to the patients. 
Additionally, the psychosocial factors may 
actually affect and modulate the perception of 
pain and related disability. Therefore, 
reassurance and counseling may minimize the 
influence of psychosocial factors.
Weight Loss
The reduction of joint reaction forces and 
symptoms of degenerative arthritis by a decrease 
in body mass is a fundamental concept in the 
management of arthritic joints (12). Obesity is an 
independent risk factor for the development of 
osteoarthritis in the knee, and this association is 
higher for women than for men (13). Weight loss 
by obese women decreases the risk of the 
development of degenerative arthritis.
Exercise and Physical Therapy
Exercise, as an adjunct to weight reduction, has 
value in the treatment of an arthritic knee. 
Stretching to prevent contracture, maintain range 
of motion, increase muscle strength, and 
increase dynamic stability of the knee can reduce 
symptoms associated with an arthritic knee. 
Quadriceps muscle weakness is common among 
patients with degenerative arthritis of the knee 
and may be a risk factor for this disease. Physical 
therapy modalities, such as cold treatment, 
hydrotherapy, superficial (hot packs, Infrared, 
paraffin) or deep heat modalities (ultrasound, 
short wave diathermy), electrotherapy 
(transcutaneous electrical nerve stimulation),
F ig .3 :
Arthroscopic view 
of the medial 
compartment of 
the knee in a 
unicompartmental 
osteoarthritic 
patient
F ig .4 a :  Schematic drawing of a preoperative condition of a 
unicompartmental osteoarthritic knee
F ig .4 b :  Postoperative schematic drawing of a patient after 
hightibial valgus osteotomy
iontophoresis, and massage can help to reduce 
the symptoms.
Support Devices and Braces
Support devices can significantly reduce the 
loading in an arthritic joint and thus decrease the 
pain associated with it. During a period of acute 
exacerbation of symptoms in a knee with 
degenerative arthritis, ambulatory support 
devices, such as a cane, one or two crutches can 
help a patient to remain active in the presence of 
a painful, swollen knee.
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Three types of knee braces are commercially 
available for treatment of a knee with degenerative 
arthritis: compression knee sleeves, supportive 
knee braces, and unloading knee braces (6). 
These may minimize swelling and provide a 
feeling of increased support and warmth about the 
knee without changing limb alignment, joint 
stability, or mechanical function. Supportive knee 
braces include hinged braces (for varus-valgus 
instability), anterior cruciate insufficiency braces 
(for anteroposterior and rotatory instability), and 
patellofemoral braces (for patellofemoral 
malalignment or instability). Unloading braces are 
designed to apply a varus or valgus force at the 
knee and relieve pain during activity by distracting 
the joint space of the involved compartment during 
weight-bearing and activity (14).
Footwear Modification and Orthotics
Well-padded, energy-absorbing shoe soles or 
orthotic devices can decrease the load across 
the knee joint during heel strike. Deformities 
leading to limb malalignment can exacerbate 
tibiofemoral arthritic symptoms. Orthotic 
correction and supportive, adaptive footwear with 
a medial longitudinal arch support, a calcaneal 
cushion, and a rigid last can improve alignment 
of the foot (6).
Heel and sole wedges can realign the foot 5° to 
10° in either the varus or the valgus plane. With 
a lateral wedge and insole, the shift in alignment 
reduces medial joint-space loading (15) (Figure
3) When knees with medial unicompartmental 
arthritis were treated with a lateral heel and sole 
wedge, more than half of the knees showed good 
or excellent results after four to twenty-four 
months of treatment (16).
Pharmatologieal therapies
Topical Agents
Topical applications of nonsteroidal anti­
inflammatory drugs (NSAIDs) and capsaicin can 
be used in OA, and are well tolerated by the 
patients. Some randomized clinical trials 
reported a significantly higher benefit of NSAID 
gels or topical preparations over placebo (4). 
Topical capsaicin results in reversible 
desensitization of the nociceptive C fibers by 
acting on VR-1 vaniloid receptors.
Some patients with unicompartmental arthritis of 
the knee report improvement with use of topical
analgesics (e.g., methyl salicylate, capsaicin, 
and nonsteroidal creams) as either adjunctive 
treatment or monotherapy (12).
Intraarticular Therapy
Acute exacerbations of knee OA presenting with 
pain, swelling, and effusion can be treated with 
aspiration of the knee joint and intra-articular 
injection of long acting corticosteroid
preparations. Corticosteroid injections can be 
combined with a local anesthetic medication. 
However, corticosteroid injections can increase 
the risk of articular cartilage damage, and they 
should not be repeated more than three or four 
times a year (6). In addition, depot formulations 
are prepared as crystals for a prolonged action, 
and they may induce a crystalline arthritis.
Intra-articular hyaluronate reduces the symptoms 
of OA and is intended to provide
viscosupplementation in the arthritic knee. It is 
administered as 3-5 weekly intraarticular 
injections. Their preparations vary in molecular 
weight from 0.5 to 6 million kDa. Because of a 
limited half life within the joint, they exert a short 
term lubricant and a biomechanical effect. It has 
also been suggested that hyaluronan therapy 
may alter the progression of arthritis of the knee 
and may decrease inflammation of the synovial 
membrane compared with that associated with 
corticosteroid injections (17). Short-term studies 
have suggested that there is no advantage of 
hyaluronic acid viscosupplementation has no 
advantage over nonsteroidal anti-inflammatory 
drugs in the treatment of an arthritic knee. The 
use of hyaluronic acid in older patients and 
patiens with severe disease provided longer- 
lasting relief of symptoms than did intra-articular 
corticosteroid injections. More information on the 
appropriate use of this treatment is expected 
from prospective, double-blind, placebo- 
controlled studies.
Oral Medications
Analgesic medications like paracetamol are the 
initial medications used to treat knee OA. These 
medications are effective in relieving pain, they 
are associated with a low incidence of side 
effects, and they are inexpensive (6). NSAIDs 
should be considered in patients unresponsive to 
paracetamol. NSAIDs are the most commonly 
used drugs in the treatment of OA of the knee 
and other joints. These drugs inhibit both
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cyclooxygenase 1 and 2, and have analgesic and 
anti-inflammatory properties, but they can be 
associated with gastrointestinal and other side 
effects. Specific cyclooxygenase-2 inhibitors 
have demonstrated clinical efficacy in the 
treatment of symptomatic arthritis of the knee, 
with decreased gastrointestinal and renal side 
effects. However, specific cyclooxygenase-2 
inhibitors are more expensive, and risk-benefit 
and cost-benefit analyses must be completed to 
better define the role of these agents (18).
Opioid analgesics, with or without paracetamol, 
are useful alternatives in patients for whom 
NSAIDs, including COX-2 selective inhibitors are 
contraindicated, ineffective, and/or poorly 
tolerated (4).
Adjunct Therapies
Nutritional supplements (nutraceutlcals), that 
appear to have medicinal properties, like 
glucosamine and chondroltln sulfate, have been 
tested in some double-blind, placebo-controlled 
randomized controlled trials. In a study by 
Reginster et al. (19), 212 patients with 
osteoarthritis of the knee were randomized to a 
glucosamine or a placebo treatment group. After 
three years of treatment, the glucosamine group 
had less joint-space narrowing and improved 
WOMAC (Western Ontario and McMaster 
University Osteoarthritis Index) scores when 
compared with the placebo group.
Studies on the structure of disease modifying 
drugs in the treatment of OA are becoming more 
popular. These drugs are Intended to retard, 
prevent or reverse the progression of OA. 
Tetracyclines, diacerrhein, avocado and soya 
unsaponifiables are promising in this respect (18).
O perative M anagem ent of Knee 
Osteoarthritis
A rthroscopy
Arthroscopy has a limited indication in the 
operative treatment of knee osteoarthiritis. 
Diagnostic arthroscopy of an arthritic knee can 
be helpful in planning the definitive surgery by 
defining the extent of the degenerative process. 
(Fig. 4) Arthroscopic surgery for 
unicompartmental arthritis of the knee can be 
useful for patients with mechanical symptoms 
(catching, clicking, locking, instability, or giving
way) that are consistent with loose meniscal 
fragments, chondral flaps, loose bodies, and/or 
impinging intercondylar spurs. On the other 
hand, joint lavage and debridement can provide 
a symptomatic treatment in osteoarthritis. No 
controlled, prospective, long-term studies have 
clearly defined the role of lavage in treatment of 
the arthritic knee. Given the studies available, it 
is fair to say that the results of this treatment 
method are Initially good but deteriorate with 
time. (20 -  23). Although a notable percentage of 
patients with arthritic knees who undergo 
arthroscopic débridement report significant relief 
of symptoms at follow-up, published rates of 
improvement at 1 year vary from 32% to 80%.
(24,25)
In the early stages of the disease, chondral 
lesions can be treated arthroscopically in order to 
stop the progression of the dejeneration. 
Arthroscopic drilling can be helpful by providing 
bleeding in subchondral tissue in order to 
stimulate new fibrocartilage formation. Cartilage 
transplantation is an other way of treatment in a 
selective group of patients in unicompartmental 
knee osteoarthiritis.
Osteotom y
Limb malalignment can accentuate stress on 
damaged articular cartilage, leading to pain, 
progressive loss of articular cartilage, and 
increasing angular deformity of the knee. The 
goal of osteotomy in the treatment of 
unicompartmental arthritis of the knee is to 
realign the limb and shift weight-bearing force 
from the degenerated tibiofemoral 
compartment to the healthier compartment. 
(Fig. 5) A stable knee with arthritis of the medial 
compartment associated with a varus 
deformity, without subluxation or lateral thrust, 
and with an arc of motion of 90° in patients, 
younger than 60 years of age with a high- 
demand, active lifestyle whose life expectancy 
exceeds the expected survival of a knee 
prosthesis may be treated with a proximal tibial 
valgus osteotomy. (26 -  30)
The aim of osteotomy in the treatment of 
unicompartmental arthritis of the knee is to 
correct the malalignment of the limb and shift 
weight-bearing force from the affected 
compartment to the healthier compartment. 
Patient selection is the most Important point for
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the success of this operation, can stop the 
progression of the disease completely or delay 
the need for knee arthroplasty surgery.
Unicompartmental Knee Arthroplasty
When restoration of the articular cartilage and 
osteotomy are not indicated, arthroplasty is 
accepted for treatment of painful 
unicompartmental arthritis. It is difficult to give 
exact criteria to choose between 
unicompartmental or total knee arthroplasty. It 
depends on the patient, knee and the surgeon. 
The ideal candidate for unicompartmental knee 
arthroplasty has low activity demands, a stable 
knee with <15° of flexion contracture, no varus or 
valgus malalignment or minimal malalignment 
that can be passively corrected on examination, 
and unicompartmental osteoarthritis with no or 
minimal degeneration of the articular cartilage of 
the contralateral compartment or patellofemoral 
joint. (31,32)
In general, unicompartmental osteoarthritis and 
osteonecrosis are possible indications for 
unicompartmental knee arthroplasty. In 
inflammatory arthritis, unicompartmental knee 
arthroplasty in contraindicated.
Total Knee Arthroplasty
Total knee arthroplasty is an accepted surgical 
treatment for painful unicompartmental 
osteoarthritis of the knee in older patients, and 
the prevalence of total knee arthroplasty is 
increasing. (33-37) Total knee arthroplasty has 
also performed well in younger patients. (38 -  
42) When patients of any age with 
unicompartmental osteoarthritis and with any 
diagnosis are poor candidates for other types of 
nonoperative and operative treatment, total knee 
arthroplasty is an option.
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